Perrigo to Present at the UBS Global Consumer and Retail Conference

Perrigo Company plc, a prominent player in the consumer health industry, has announced its upcoming presentation at the UBS Global Consumer and Retail Conference. Scheduled for March 11, 2026, at 11:00 AM EDT, the company's President and CEO, Patrick Lockwood-Taylor, will address attendees, offering insights into Perrigo’s strategies and market performance.

Investors and interested parties can access the presentation via a live webcast on Perrigo's official website, showcasing the company’s commitment to transparency and communication with stakeholders. With over a century of experience, Perrigo has established itself as a leader in providing high-quality health and wellness products, primarily catering to consumers in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, or without prescription products, Perrigo focuses on delivering consumers accessible and reliable self-care solutions across diverse molecules and dosage forms.

Perrigo's business model effectively integrates cash-generative store brand offerings, which bolster investments in established brands such as Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®. This unique approach not only enhances the company’s product range but also positions it for sustained growth.

Furthermore, the press release emphasizes that the forthcoming presentation may contain "forward-looking statements," highlighting the inherent risks and uncertainties in predicting future outcomes. Interested investors are encouraged to review Perrigo’s filings with the U.S. Securities and Exchange Commission for comprehensive insights into the company’s financial health and potential risks.

For more details and updates, stakeholders can visit Perrigo’s investor relations page or contact their investor relations representatives directly.

As Perrigo Company plc (NYSE: PRGO) prepares to present at the UBS Global Consumer and Retail Conference on March 11, market watchers should closely evaluate the company's current position within the consumer health sector. With a century-long legacy in providing over-the-counter (OTC) health solutions, Perrigo stands out as a significant player in the industry, particularly in North America and Europe.

The upcoming presentation by President and CEO Patrick Lockwood-Taylor will likely emphasize Perrigo's robust business model that integrates both store brand private label products and well-established brands such as Opill®, Mederma®, and Compeed®. This dual strategy not only drives cash flow but also allows the company to reinvest in innovation, ensuring it remains competitive in the fast-evolving self-care market.

Investors should pay attention to any updates on product lines and potential new launches, especially in light of ongoing shifts in consumer preferences towards health and wellness. Global economic factors, including inflation and shifting healthcare policies, could also impact growth forecasts, making this presentation a crucial one for assessing future performance.

Furthermore, given the forward-looking nature of the conference, it's important to listen for any discussions regarding challenges the company may face, such as supply chain disruptions or regulatory hurdles, as highlighted in its recent filings. The potential risks mentioned could sway investor sentiment and impact share price volatility.

In conclusion, attending the presentation offers valuable insights into Perrigo's strategic direction and market positioning. As the global consumer health landscape continues to evolve, staying informed on Perrigo's developments will be key for existing and potential investors looking to capitalize on market opportunities.